SCHEMBL479247

SCHEMBL479247

CCOC(=O)c1cccc2[nH]c3ccccc3c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.62
MAPT P10636 4/20 0.58
ALDH1A1 P00352 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MEN1 O00255 1/20 0.58
HCRTR1 O43613 1/20 0.58
RAB9A P51151 1/20 0.58
KMT2A Q03164 1/20 0.58
TSHR P16473 1/20 0.57
CDC25B P30305 2/20 0.54
GABRP O00591 2/20 0.53
GABRD O14764 2/20 0.53
GABRA1 P14867 2/20 0.53
GABRB1 P18505 2/20 0.53
GABRG2 P18507 2/20 0.53
GABRB3 P28472 2/20 0.53
GABRA5 P31644 2/20 0.53
GABRA3 P34903 2/20 0.53
GABRA2 P47869 2/20 0.53
GABRB2 P47870 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6009595 0.89 TSHR (0.61) KDM4EMAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL5794647 0.86 KDM4E (0.59) KDM4EMAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL10642644 0.84 KDM5A (0.55) KDM4EMAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL6008342 0.84 TSHR (0.54) KDM4EMAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL10642534 0.83 GABRP (0.58) KDM4EMAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL2181558 0.83 NR4A2 (0.55) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL30522265 0.83 NR4A2 (0.55) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL31670359 0.83 NR4A2 (0.55) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL12500666 0.83 ALDH1A1 (0.55) KDM4EALDH1A1RAB9AKMT2ATSHR
Hydrochloric Acid SCHEMBL10641678 0.82 GABRP (0.57) KDM4EMAPTALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015040087-A1 MACROPHAGE IMAGING GE HEALTHCARE LIMITED (GB) 2015-03-26 WO disclosed
EP-2621544-A1 IN VIVO IMAGING METHOD FOR CANCER GE Healthcare UK Limited (GB) 2013-08-07 EP disclosed
EP-2618850-A1 IN VIVO IMAGING METHOD OF MOOD DISORDERS GE Healthcare UK Limited (GB) 2013-07-31 EP disclosed
US-8486990-B2 SirT inhibitors that bind to NAD ELIXIR PHARMACEUTICALS, INC. (US) 2013-07-16 US disclosed
WO-2012041953-A1 IN VIVO IMAGING METHOD FOR CANCER GE HEALTHCARE LIMITED (GB) 2012-04-05 WO disclosed
WO-2012038532-A1 IN VIVO IMAGING METHOD OF MOOD DISORDERS GE HEALTHCARE LIMITED (GB) 2012-03-29 WO disclosed
EP-2411362-A2 INDOLE DERIVATIVES GE Healthcare UK Limited (GB) 2012-02-01 EP disclosed
WO-2010109007-A2 INDOLE DERIVATIVES GE HEALTHCARE LIMITED (GB) 2010-09-30 WO disclosed
US-20060183022-A1 Electrochemical cell NEC TOKIN CORORATION (JP) 2006-08-17 US disclosed